Gene info: ID 79718

Gene: TBL1XR1

GENE ID: 79718

Synonyms: C21|DC42|IRA1|MRD41|TBLR1

Description: transducin beta like 1 X-linked receptor 1

Gene type: protein-coding

Location: 3q26.32

dbXrefs: Ensembl:ENSG00000177565 MIM:608628 Vega:OTTHUMG00000157140 UniprotKB:Q9BZK7

RefSeq: NG_047195.1

Retrived from: SNP Mapped

SNPs: 3 ANCO-SNPs

Phenotype: AD

# Publications: 0

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 3.199e-1 (AD) 4.246e-1 (ND)

ANCO-SNPs

SNP ID	Position	Alleles	Trait	Variation Type
rs7632766	chr3:177150265 (GRCh38.p7)	T>C	alcohol dependence	SNV(Single Nucleotide Variation)
rs1209035	chr3:177110139 (GRCh38.p7)	T>C	alcohol dependence	SNV(Single Nucleotide Variation)
rs1201284	chr3:177089526 (GRCh38.p7)	G>A / G>T	alcohol dependence	SNV(Single Nucleotide Variation)

DNA Methylation

Probe	Locus(GRCh37)	Gene	Region	p-val	Trait	PubMed ID
cg13273540	chr3:176850227	TBL1XR1	Promoter	9.724e-5	Alcohol use disorders	26763658
cg06657944	chr3:176915062	TBL1XR1		1.810e-8	Alcohol consumption der day	27843151

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
RAB6A	0.954
SPIN1	0.954
MATR3	0.952
MARCH6	0.951
USP33	0.951
ARL8B	0.95
ATP6AP2	0.95
REEP5	0.948
RAB2A	0.947
NDFIP1	0.947

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
OR4F5	-0.697
OR4F29	-0.662
CSAG1	-0.386
TFPI2	-0.338
MTRNR2L10	-0.324
CXCR2	-0.316
RUNX3	-0.315
KCNJ15	-0.314
PGF	-0.311
CNN2	-0.303

There is no DrugBank record for this gene !

ID	Drug Name	Action	PubMed
C028474	1,4-bis(2-(3,5-dichloropyridyloxy))benzene	"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of TBL1XR1 mRNA"	22698814
C023514	2,6-dinitrotoluene	"2,6-dinitrotoluene affects the expression of TBL1XR1 mRNA"	21346803
C472791	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid	3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of TBL1XR1 mRNA	12958071
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in increased expression of TBL1XR1 mRNA	19191707
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
D000082	Acetaminophen	Acetaminophen results in decreased expression of TBL1XR1 mRNA	21420995\|2223033
D020106	Acrylamide	Acrylamide results in decreased expression of TBL1XR1 mRNA	28959563
D001151	Arsenic	Arsenic affects the methylation of TBL1XR1 gene	25304211
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of TBL1XR1 mRNA	19770486
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TBL1XR1 mRNA"	19150397\|2001819
D004958	Estradiol	Estradiol results in decreased expression of TBL1XR1 mRNA	20068009
C006780	bisphenol A	bisphenol A affects the expression of TBL1XR1 mRNA	21786754
C006780	bisphenol A	bisphenol A affects the methylation of TBL1XR1 promoter	27334623
C006780	bisphenol A	bisphenol A results in decreased expression of TBL1XR1 mRNA	25181051
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA	23410634
C018475	butyraldehyde	butyraldehyde results in decreased expression of TBL1XR1 mRNA	26079696
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of TBL1XR1 mRNA	26472689
D002251	Carbon Tetrachloride	Carbon Tetrachloride affects the expression of TBL1XR1 mRNA	17484886
C099555	CD 437	CD 437 results in decreased expression of TBL1XR1 mRNA	12958071
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in decreased expression of TBL1XR1 mRNA	23650126
D002737	Chloroprene	Chloroprene results in increased expression of TBL1XR1 mRNA	23125180
D004390	Chlorpyrifos	Chlorpyrifos results in decreased expression of TBL1XR1 mRNA	18668222
D002995	Clofibric Acid	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL1XR1 mRNA	17602206
D003300	Copper	[NSC 689534 binds to Copper] which results in decreased expression of TBL1XR1 mRNA	20971185
D003300	Copper	Copper results in increased expression of TBL1XR1 mRNA	16629173
D019327	Copper Sulfate	Copper Sulfate results in decreased expression of TBL1XR1 mRNA	19549813
D003907	Dexamethasone	Dexamethasone results in increased expression of TBL1XR1 mRNA	22733784
D002945	Cisplatin	Cisplatin results in decreased expression of TBL1XR1 mRNA	19561079\|2739243
C000944	dicrotophos	dicrotophos results in decreased expression of TBL1XR1 mRNA	28302478
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL1XR1 mRNA	17602206
D004052	Diethylnitrosamine	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TBL1XR1 mRNA	22129741
D015127	9,10-Dimethyl-1,2-benzanthracene	"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TBL1XR1 mRNA"	22485181
D004317	Doxorubicin	Doxorubicin results in increased expression of TBL1XR1 mRNA	25896364
C045651	epigallocatechin gallate	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBL1XR1 mRNA	22079256
D005020	Ethyl Methanesulfonate	Ethyl Methanesulfonate results in decreased expression of TBL1XR1 mRNA	23649840
D005485	Flutamide	Flutamide results in decreased expression of TBL1XR1 mRNA	21126777
D005485	Flutamide	Flutamide results in decreased expression of TBL1XR1 mRNA	24793618
D005557	Formaldehyde	Formaldehyde results in decreased expression of TBL1XR1 mRNA	23649840
D005897	Glafenine	Glafenine results in decreased expression of TBL1XR1 mRNA	24136188
D006046	Gold	Gold results in decreased expression of TBL1XR1 mRNA	25523186
D017313	Fenretinide	Fenretinide results in decreased expression of TBL1XR1 mRNA	28973697
D006861	Hydrogen Peroxide	Hydrogen Peroxide affects the expression of TBL1XR1 mRNA	20044591\|2341063
C016517	indole-3-carbinol	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TBL1XR1 mRNA	22129741
D007545	Isoproterenol	Isoproterenol results in increased expression of TBL1XR1 mRNA	20003209
C544151	jinfukang	jinfukang results in decreased expression of TBL1XR1 mRNA	27392435
C561695	(+)-JQ1 compound	(+)-JQ1 compound affects the expression of TBL1XR1 mRNA	26733615
C561695	(+)-JQ1 compound	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of TBL1XR1 mRNA]	26733615
C561695	(+)-JQ1 compound	(+)-JQ1 compound results in decreased expression of TBL1XR1 mRNA	23430699\|2479639
C561695	(+)-JQ1 compound	panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of TBL1XR1 mRNA]	26733615
C008261	lead acetate	lead acetate results in decreased expression of TBL1XR1 mRNA	25270620
C045463	leflunomide	leflunomide results in increased expression of TBL1XR1 mRNA	28988120
C045463	leflunomide	leflunomide results in increased expression of TBL1XR1 mRNA	24136188
D008558	Melphalan	Melphalan results in decreased expression of TBL1XR1 mRNA	22363485
D008727	Methotrexate	Methotrexate results in decreased expression of TBL1XR1 mRNA	24449571
D008748	Methylcholanthrene	Methylcholanthrene promotes the reaction [AHR protein binds to TBL1XR1 promoter]	20348232
C004925	methylmercuric chloride	methylmercuric chloride results in decreased expression of TBL1XR1 mRNA	28001369
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in decreased expression of TBL1XR1 mRNA	23649840
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of TBL1XR1 mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in increased expression of TBL1XR1 mRNA"	25620056
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in decreased expression of TBL1XR1 mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of TBL1XR1 mRNA"	25620056
C558013	NSC 689534	[NSC 689534 binds to Copper] which results in decreased expression of TBL1XR1 mRNA	20971185
C030110	oxaliplatin	[oxaliplatin co-treated with Topotecan] results in decreased expression of TBL1XR1 mRNA	25729387
C496932	panobinostat	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of TBL1XR1 mRNA]	26733615
C496932	panobinostat	panobinostat affects the expression of TBL1XR1 mRNA	26733615
C496932	panobinostat	panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of TBL1XR1 mRNA]	26733615
C016030	pantogab	pantogab results in increased expression of TBL1XR1 mRNA	17379144
D010662	Phenylmercuric Acetate	"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
D010662	Phenylmercuric Acetate	Phenylmercuric Acetate results in decreased expression of TBL1XR1 mRNA	26272509
D010795	Phthalic Acids	Phthalic Acids results in increased expression of TBL1XR1 mRNA	21061450
C006253	pirinixic acid	pirinixic acid results in increased expression of TBL1XR1 mRNA	18301758\|1844570
C006253	pirinixic acid	PPARA protein affects the reaction [pirinixic acid results in increased expression of TBL1XR1 mRNA]	21318169
C027373	potassium chromate(VI)	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TBL1XR1 mRNA	22079256
C027373	potassium chromate(VI)	potassium chromate(VI) results in decreased expression of TBL1XR1 mRNA	22079256
D011285	Pregnenolone Carbonitrile	Pregnenolone Carbonitrile results in increased expression of TBL1XR1 mRNA	28903501
C059514	resveratrol	resveratrol results in decreased expression of TBL1XR1 mRNA	25905778
D015474	Isotretinoin	Isotretinoin results in increased expression of TBL1XR1 mRNA	20436886
C513635	S-2-pentyl-4-pentynoic hydroxamic acid	S-2-pentyl-4-pentynoic hydroxamic acid results in decreased expression of TBL1XR1 mRNA	21427059
D012834	Silver	Silver results in decreased expression of TBL1XR1 mRNA	27131904
C017947	sodium arsenite	sodium arsenite results in decreased expression of TBL1XR1 mRNA	25270620
D018038	Sodium Selenite	Sodium Selenite results in decreased expression of TBL1XR1 mRNA	18175754
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to TBL1XR1 gene]	19574409
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of TBL1XR1 mRNA	19574409
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of TBL1XR1 mRNA	21570461
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of TBL1XR1 mRNA	21354282
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of TBL1XR1 mRNA	22298810
D013750	Tetrachloroethylene	Tetrachloroethylene results in increased expression of TBL1XR1 mRNA	28973375
D013849	Thimerosal	Thimerosal results in increased expression of TBL1XR1 mRNA	27188386
D013853	Thioacetamide	Thioacetamide results in increased expression of TBL1XR1 mRNA	23411599
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of TBL1XR1 mRNA	28065790
D019772	Topotecan	[oxaliplatin co-treated with Topotecan] results in decreased expression of TBL1XR1 mRNA	25729387
C483909	torcetrapib	torcetrapib results in increased expression of TBL1XR1 mRNA	23228038
C012589	trichostatin A	"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
C012589	trichostatin A	trichostatin A results in decreased expression of TBL1XR1 mRNA	24935251\|2627250
C015559	trimellitic anhydride	trimellitic anhydride results in increased expression of TBL1XR1 mRNA	19042947
C057693	troglitazone	troglitazone results in decreased expression of TBL1XR1 mRNA	28973697
D014635	Valproic Acid	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA"	27188386
D014635	Valproic Acid	Valproic Acid affects the expression of TBL1XR1 mRNA	25979313
D014635	Valproic Acid	Valproic Acid results in decreased expression of TBL1XR1 mRNA	23179753\|2438349
D014635	Valproic Acid	Valproic Acid affects the expression of TBL1XR1 mRNA	17292431
D014635	Valproic Acid	Valproic Acid results in decreased expression of TBL1XR1 mRNA	21427059
D001335	Vehicle Emissions	Vehicle Emissions affects the methylation of TBL1XR1 gene	25560391
C025643	vinclozolin	vinclozolin affects the expression of TBL1XR1 mRNA	19015723
D024483	Vitamin K 3	Vitamin K 3 affects the expression of TBL1XR1 mRNA	23410634
C088658	zoledronic acid	zoledronic acid results in increased expression of TBL1XR1 mRNA	20977926

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0003714	transcription corepressor activity	-	IBA	21873635
GO:0003714	transcription corepressor activity	-	IDA	12628926
GO:0003714	transcription corepressor activity	-	IGI	15601853
GO:0005515	protein binding	-	IPI	12628926 25416956 28348241
GO:0008013	beta-catenin binding	-	IPI	18193033
GO:0042393	histone binding	-	IDA	15601853
GO:0044212	transcription regulatory region DNA binding	-	IDA	18193033
GO:0044212	transcription regulatory region DNA binding	-	ISS	-
GO:0047485	protein N-terminus binding	-	IPI	16893456

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000122	negative regulation of transcription by RNA polymerase II	-	IDA	12628926
GO:0002021	response to dietary excess	-	IEA	-
GO:0006351	transcription, DNA-templated	-	IEA	-
GO:0006357	regulation of transcription by RNA polymerase II	-	IBA	21873635
GO:0016042	lipid catabolic process	-	IEA	-
GO:0016575	histone deacetylation	-	IBA	21873635
GO:0019216	regulation of lipid metabolic process	-	TAS	-
GO:0035264	multicellular organism growth	-	IEA	-
GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	-	ISS	-
GO:0045893	positive regulation of transcription, DNA-templated	-	IDA	18193033
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IDA	18193033
GO:0050872	white fat cell differentiation	-	IEA	-
GO:0060613	fat pad development	-	IEA	-
GO:0090207	regulation of triglyceride metabolic process	-	IEA	-
GO:0090263	positive regulation of canonical Wnt signaling pathway	-	IMP	18193033

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000118	histone deacetylase complex	-	IBA	21873635
GO:0000118	histone deacetylase complex	colocalizes_with	IDA	18326024
GO:0005634	nucleus	-	IDA	18193033
GO:0005654	nucleoplasm	-	TAS	-
GO:0005876	spindle microtubule	-	IDA	18326024
GO:0017053	transcriptional repressor complex	-	IDA	12628926 15601853

KEGG ID	KEGG Term
hsa04310	Wnt signaling pathway

Reactome ID	Reactome Term	Evidence
R-HSA-1266738	Developmental Biology	TAS
R-HSA-1368082	RORA activates gene expression	TAS
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	IEA
R-HSA-1430728	Metabolism	TAS
R-HSA-1430728	Metabolism	IEA
R-HSA-157118	Signaling by NOTCH	IEA
R-HSA-1592230	Mitochondrial biogenesis	TAS
R-HSA-162582	Signal Transduction	IEA
R-HSA-1643685	Disease	TAS
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	TAS
R-HSA-1852241	Organelle biogenesis and maintenance	TAS
R-HSA-1980143	Signaling by NOTCH1	IEA
R-HSA-1989781	PPARA activates gene expression	TAS
R-HSA-1989781	PPARA activates gene expression	IEA
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	IEA
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	TAS
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	TAS
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	TAS
R-HSA-2644603	Signaling by NOTCH1 in Cancer	TAS
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	TAS
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	TAS
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	TAS
R-HSA-3214815	HDACs deacetylate histones	TAS
R-HSA-3247509	Chromatin modifying enzymes	TAS
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	TAS
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	TAS
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	IEA
R-HSA-400253	Circadian Clock	TAS
R-HSA-400253	Circadian Clock	IEA
R-HSA-4839726	Chromatin organization	TAS
R-HSA-556833	Metabolism of lipids	TAS
R-HSA-556833	Metabolism of lipids	IEA
R-HSA-5663202	Diseases of signal transduction	TAS
R-HSA-8957322	Metabolism of steroids	TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal